Across-cities transportable 13C hyperpolarization using UV-induced labile radicals

Hyperpolarized ¹³ C Magnetic Resonance Spectroscopic Imaging (HP ¹³ C-MRSI) has the potential to transform diagnostic radiology thanks to its unique ability to noninvasively detect a broad range of diseases entailing aberrant metabolism. However, clinical adoption has been hindered by the short lifetime of ¹³ C-hyperpolarization and the resulting need for on-site polarizers near the MR scanner. In this work, we present a solution for long-lived transportable HP molecular contrast agents that uses dissolution Dynamic Nuclear Polarization (dDNP) combined with UV-induced labile radicals. This approach allows centralized pre-polarization and transport under hours-long storage T1 conditions. We validate this concept through the first across-cities HP ¹³ C-MRSI experiments in vivo on a clinical MRI system, using both a perfusion/angiography agent ([1- ¹³ C]HP001) and a metabolic ([U- ¹³ C, d7]glucose) contrast agent. Our findings advance the feasibility of decentralized, scalable HP MRI workflows, removing the barrier of on-site infrastructure and moving the field closer to clinical translation.